论文部分内容阅读
目的:探讨糖化血红蛋白(HbA1c)表达水平对判断中老年人脑卒中患者预后的临床价值。方法:对2013年12月至2015年12月在笔者所在医院就诊的脑卒中患者196例进行回顾性分析研究,根据诊断患者HbA1c值的不同将其分为A、B、C 3组,各组患者HbA1c值分别为<155 mg·dl~(-1),155~199 mg·dl~(-1),>199 mg·dl~(-1)。对各病例的预后及疗效进行分析比较。结果:B、C组患者的NIHSS评分、Rankin评分、发展性卒中例数、住院天数及死亡率与A组相比均偏高,且差异有统计学意义(P<0.05)。结论:HbA1c升高的患者其发展性卒中例数及死亡率高,住院天数延长,对患者生活质量带来极大危害,应在临床上加以重视。
Objective: To investigate the clinical value of HbA1c expression in judging the prognosis of middle-aged and elderly patients with stroke. Methods: A retrospective analysis was performed on 196 stroke patients who visited our hospital from December 2013 to December 2015. The HbA1c values of the patients were divided into A, B and C groups according to their diagnostic value. Each group Patients with HbA1c values of <155 mg · dl -1, 155 ~ 199 mg · dl -1 and> 199 mg · dl -1, respectively. The prognosis and efficacy of each case were analyzed and compared. Results: The NIHSS score, Rankin score, the number of developmental stroke, hospitalization days and mortality in group B and group C were all higher than those in group A, and the difference was statistically significant (P <0.05). CONCLUSION: Patients with elevated HbA1c have a high incidence of stroke and mortality, prolonged hospital stay, and great harm to the quality of life of patients.